Description
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 1/00: Drugs for disorders of the alimentary tract or the digestive system
A61P 1/00
Sub-Class
Stats
- 689 US PATENTS IN FORCE
- 240 US APPLICATIONS PENDING
- 183 Total Patent Owners
- 13,027 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12005094 | Inhibitor of inflammatory conditions | Mar 04, 21 | Jun 11, 24 | Not available |
| 12005124 | Muscle targeting complexes and uses thereof for treating dystrophinopathies | Oct 24, 23 | Jun 11, 24 | Dyne Therapeutics, Inc. |
| 11992497 | Cannabinoid derivatives and their use | Apr 12, 23 | May 28, 24 | DEMEETRA AGBIO, INC. |
| 11992511 | strain and use thereof | Feb 16, 22 | May 28, 24 | KoBioLabs, Inc. |
| 11986487 | Mixture of HMOS for treating wheat sensitivity | Sep 21, 22 | May 21, 24 | GLYCOM A/S |
| 11987644 | Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodies | Apr 09, 20 | May 21, 24 | Novartis AG |
| 11980595 | Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases | Feb 14, 19 | May 14, 24 | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY |
| 11981657 | Substituted benzimidazoles, their preparation and their use as pharmaceuticals | May 13, 22 | May 14, 24 | EPIGENETIX, INC. |
| 11975016 | -substituted purine nucleotides for RNA virus treatment | Sep 22, 21 | May 07, 24 | Atea Pharmaceuticals, Inc. |
| 11975023 | Methods for inhibiting anaerobic microorganisms | Feb 14, 23 | May 07, 24 | LPOXY Therapeutics, Inc. |
| 11975046 | Medical use of interferon-lambda for the treatment of fibrosis | Jun 29, 23 | May 07, 24 | UCB Biopharma SRL; Five Prime Therapeutics, Inc.; |
| 11969446 | Compositions comprising bacterial species and methods related thereto | Aug 28, 20 | Apr 30, 24 | XBIOME INC. |
| 11963988 | Lactic acid bacteria and use thereof | Apr 06, 22 | Apr 23, 24 | University-Industry Cooperation Group of Kyung Hee University; Navipharm Co., Ltd.; |
| 11938156 | Lactic acid bacteria and its applications | Jan 04, 19 | Mar 26, 24 | BENED BIOMEDICAL CO., LTD. |
| 11931386 | Compositions and methods for increasing butyrate production | Aug 29, 18 | Mar 19, 24 | The Regents of the University of Michigan |
| 11925634 | Use of koumine in preparation of medicament for treatment of inflammatory bowel disease | Jul 10, 20 | Mar 12, 24 | Fujian Medical University |
| 11925688 | Compositions and methods relating to salts of specialized pro-resolving mediators | Oct 01, 21 | Mar 12, 24 | Thetis Pharmaceuticals LLC |
| 11918553 | Anti-oncogenic phytochemicals comprising substituted henicosanoic acid and henicosenoic acid | Jun 16, 23 | Mar 05, 24 | Ostentus Therapeutics, Inc. |
| 11919854 | P2RX7 modulators in therapy | Mar 29, 19 | Mar 05, 24 | Centre National De La Recherche Scientifique (CNRS); CHRU DE LILLE; Communaute Universites et Etablissements Universite Cote D Azur; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); Universite de Lille 2; JUNIA; |
| 11911409 | Pharmaceutical composition for treatment and prevention of chronic disease | Oct 20, 21 | Feb 27, 24 | STELIC INSTITUTE & CO., INC. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0180,918 | NOVEL USE OF PYRROLOPYRIDINE DERIVATIVES FOR PREVENTING OR TREATING INFLAMMATORY DISEASES | Oct 13, 23 | Jun 06, 24 | Not available |
| 2024/0180,955 | FIBER SUPPLEMENTATION PROTECTS FROM ANTIBIOTIC-INDUCED GUT MICROBIOME DYSBIOSIS BY MODULATING REDOX METABOLISM | Oct 05, 23 | Jun 06, 24 | Not available |
| 2024/0182,581 | METHODS FOR THE TREATMENT OF CHRONIC POUCHITIS | Jun 29, 23 | Jun 06, 24 | Not available |
| 2024/0182,446 | TYK2 INHIBITOR COMPOUND CONTAINING BICYCLIC RING | Jan 30, 22 | Jun 06, 24 | Not available |
| 2024/0173,288 | COMPOUNDS, COMPOSITIONS, METHODS OF USING, AND METHODS FOR PREPARING COMPOUNDS | Oct 26, 23 | May 30, 24 | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.; THE INSTITUTE FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE (INSTEM); |
| 2024/0173,436 | COMPACT PROMOTERS FOR GENE EXPRESSION | Mar 31, 22 | May 30, 24 | Not available |
| 2024/0174,688 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | Oct 05, 23 | May 30, 24 | Not available |
| 2024/0174,690 | ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER | May 09, 23 | May 30, 24 | Not available |
| 2024/0174,728 | A USE OF A POLYPEPTIDE COMPOUND IN THE PREPARATION OF DRUGS FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASES AND RELATED INTESTINAL FIBROSIS | Aug 09, 21 | May 30, 24 | Not available |
| 2024/0165,168 | ENGINEERED BACTERIA SECRETING THERAPEUTIC PROTEINS AND METHODS OF USE THEREOF | Nov 29, 23 | May 23, 24 | Not available |
| 2024/0165,037 | Colonic Microbiota Responsive Polymer And Its Preparation Method And Use | Sep 26, 23 | May 23, 24 | Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine |
| 2024/0165,051 | USE OF ATOVAQUONE AND PROGUANIL FOR TREATMENT OF GASTROINTESTINAL DISEASES AND INFLAMMATION | Jan 24, 24 | May 23, 24 | Elevaid Therapeutics, Inc. |
| 2024/0165,109 | Methods of Treatment with Selective CB2 Receptor Agonists | Mar 01, 22 | May 23, 24 | Arena Pharmaceuticals, Inc. |
| 2024/0165,149 | NUTRACEUTICAL COMPOSITION COMPRISING INULIN FOR TREATING AND PREVENTING OCULAR DISORDERS OR INTESTINAL MICROBIOTA IMBALANCE | Mar 22, 22 | May 23, 24 | Not available |
| 2024/0165,171 | COMPOSITION FOR ENHANCING PHYSIOLOGICAL EFFICACY OF LACTIC ACID BACTERIA | Mar 23, 22 | May 23, 24 | Not available |
| 2024/0165,181 | COMPOSITION FOR INHIBITING INTESTINAL PERMEABILITY, TREATING LEAKY GUT RELATED DISEASES AND/OR PREVENTING LEAKY GUT RELATED DISEASES | Jun 01, 23 | May 23, 24 | (6) INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE |
| 2024/0165,193 | Treatment of Ascites | Jan 23, 24 | May 23, 24 | Not available |
| 2024/0165,253 | ANTI-C-MET ANTIBODY-DRUG CONJUGATE AND APPLICATIONS THEREOF | Aug 31, 21 | May 23, 24 | Not available |
| 2024/0148,671 | METHODS FOR IMPROVING POULTRY HEALTH | Mar 10, 22 | May 09, 24 | Not available |
| 2024/0148,798 | TREATMENT OR PREVENTION OF GASTROINTESTINAL DYSBIOSIS | Jan 16, 24 | May 09, 24 | NORGES MILJO-OG BIOVITENSKAPELIGE UNIVERSITET (NMBU); SYKEHUSET OSTFOLD HF; University of Copenhagen; |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)